Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2014. Start Trial.
Date Value
October 02, 2026 3.895
October 01, 2026 3.812
September 30, 2026 4.134
September 29, 2026 4.014
September 28, 2026 4.129
September 25, 2026 4.109
September 24, 2026 4.148
September 23, 2026 4.302
September 22, 2026 4.441
September 21, 2026 4.332
September 18, 2026 4.416
September 17, 2026 4.402
September 16, 2026 4.505
September 15, 2026 4.382
September 14, 2026 4.457
September 11, 2026 4.264
September 10, 2026 4.475
September 09, 2026 4.563
September 08, 2026 4.651
September 04, 2026 4.601
September 03, 2026 4.609
September 02, 2026 4.573
September 01, 2026 4.623
August 31, 2026 4.649
August 28, 2026 4.633
Date Value
August 27, 2026 4.794
August 26, 2026 4.870
August 25, 2026 4.854
August 24, 2026 4.822
August 21, 2026 4.876
August 20, 2026 4.918
August 19, 2026 4.979
August 18, 2026 4.804
August 17, 2026 4.635
August 14, 2026 4.433
August 13, 2026 4.414
August 12, 2026 4.593
August 11, 2026 4.611
August 10, 2026 4.629
August 07, 2026 4.736
August 06, 2026 4.519
August 05, 2026 4.230
August 04, 2026 4.184
August 03, 2026 3.876
July 31, 2026 3.798
July 30, 2026 3.995
July 29, 2026 3.991
July 28, 2026 3.917
July 27, 2026 3.955
July 24, 2026 3.868

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 2.648
Alnylam Pharmaceuticals, Inc. 21.72
Savara, Inc. 6.841
Vericel Corp. 5.685
Biogen, Inc. 1.751

Price to Book Value Related Metrics

PS Ratio 25.79
Price 19.00
Earnings Yield -19.52%
Market Cap 2.151B